Stopping Randomized Trials Early for Benefit and Estimation of Treatment Effects Systematic Review and Meta-regression Analysis

被引:454
作者
Bassler, Dirk [2 ,3 ]
Briel, Matthias [2 ,4 ]
Montori, Victor M. [1 ]
Lane, Melanie [1 ]
Glasziou, Paul [5 ]
Zhou, Qi [2 ]
Heels-Ansdell, Diane [2 ]
Walter, Stephen D. [2 ]
Guyatt, Gordon H. [2 ]
机构
[1] Mayo Clin, Knowledge & Encounter Res Unit, Rochester, MN 55905 USA
[2] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada
[3] Univ Childrens Hosp Tuebingen, Dept Neonatol, Tubingen, Germany
[4] Univ Basel Hosp, Basel Inst Clin Epidemiol & Biostat, CH-4031 Basel, Switzerland
[5] Univ Oxford, Dept Primary Hlth Care, Ctr Evidence Based Med, Oxford, England
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2010年 / 303卷 / 12期
基金
加拿大健康研究院; 瑞士国家科学基金会; 英国医学研究理事会;
关键词
CLINICAL-TRIALS; INTERIM ANALYSES; EFFICACY;
D O I
10.1001/jama.2010.310
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Theory and simulation suggest that randomized controlled trials (RCTs) stopped early for benefit (truncated RCTs) systematically overestimate treatment effects for the outcome that precipitated early stopping. Objective To compare the treatment effect from truncated RCTs with that from meta-analyses of RCTs addressing the same question but not stopped early (nontruncated RCTs) and to explore factors associated with overestimates of effect. Data Sources Search of MEDLINE, EMBASE, Current Contents, and full-text journal content databases to identify truncated RCTs up to January 2007; search of MEDLINE, Cochrane Database of Systematic Reviews, and Database of Abstracts of Reviews of Effects to identify systematic reviews from which individual RCTs were extracted up to January 2008. Study Selection Selected studies were RCTs reported as having stopped early for benefit and matching nontruncated RCTs from systematic reviews. Independent reviewers with medical content expertise, working blinded to trial results, judged the eligibility of the nontruncated RCTs based on their similarity to the truncated RCTs. Data Extraction Reviewers with methodological expertise conducted data extraction independently. Results The analysis included 91 truncated RCTs asking 63 different questions and 424 matching nontruncated RCTs. The pooled ratio of relative risks in truncated RCTs vs matching nontruncated RCTs was 0.71 (95% confidence interval, 0.65-0.77). This difference was independent of the presence of a statistical stopping rule and the methodological quality of the studies as assessed by allocation concealment and blinding. Large differences in treatment effect size between truncated and nontruncated RCTs (ratio of relative risks <0.75) occurred with truncated RCTs having fewer than 500 events. In 39 of the 63 questions (62%), the pooled effects of the nontruncated RCTs failed to demonstrate significant benefit. Conclusions Truncated RCTs were associated with greater effect sizes than RCTs not stopped early. This difference was independent of the presence of statistical stopping rules and was greatest in smaller studies. JAMA. 2010; 303(12): 1180-1187
引用
收藏
页码:1180 / 1187
页数:8
相关论文
共 22 条
  • [1] Early stopping of randomized clinical trials for overt efficacy is problematic
    Bassler, Dirk
    Montori, Victor M.
    Briel, Matthias
    Glasziou, Paul
    Guyatt, Gordon
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 2008, 61 (03) : 241 - 246
  • [2] Systematic reviewers neglect bias that results from trials stopped early for benefit
    Bassler, Dirk
    Ferreira-Gonzalez, Ignacio
    Briel, Matthias
    Cook, Deborah J.
    Devereaux, P. J.
    Heels-Ansdell, Diane
    Kirpalani, Haresh
    Meade, Maureen O.
    Montori, Victor M.
    Rozenberg, Anna
    Schuenemann, Holger J.
    Guyatt, Gordon H.
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 2007, 60 (09) : 869 - 873
  • [3] Stopping randomized trials early for benefit: a protocol of the Study Of Trial Policy Of Interim Truncation-2 (STOPIT-2)
    Briel, Matthias
    Lane, Melanie
    Montori, Victor M.
    Bassler, Dirk
    Glasziou, Paul
    Malaga, German
    Akl, Elie A.
    Ferreira-Gonzalez, Ignacio
    Alonso-Coello, Pablo
    Urrutia, Gerard
    Kunz, Regina
    Culebro, Carolina Ruiz
    da Silva, Suzana Alves
    Flynn, David N.
    Elamin, Mohamed B.
    Strahm, Brigitte
    Murad, M. Hassan
    Djulbegovic, Benjamin
    Adhikari, Neill K. J.
    Mills, Edward J.
    Gwadry-Sridhar, Femida
    Kirpalani, Haresh
    Soares, Heloisa P.
    Abu Elnour, Nisrin O.
    You, John J.
    Karanicolas, Paul J.
    Bucher, Heiner C.
    Lampropulos, Julianna F.
    Nordmann, Alain J.
    Burns, Karen E. A.
    Mulla, Sohail M.
    Raatz, Heike
    Sood, Amit
    Kaur, Jagdeep
    Bankhead, Clare R.
    Mullan, Rebecca J.
    Nerenberg, Kara A.
    Vandvik, Per Olav
    Coto-Yglesias, Fernando
    Schuenemann, Holger
    Tuche, Fabio
    Chrispim, Pedro Paulo M.
    Cook, Deborah J.
    Lutz, Kristina
    Ribic, Christine M.
    Vale, Noah
    Erwin, Patricia J.
    Perera, Rafael
    Zhou, Qi
    Heels-Ansdell, Diane
    [J]. TRIALS, 2009, 10
  • [4] Stopping clinical trials early for benefit: impact on estimation
    Freidlin, Boris
    Korn, Edward L.
    [J]. CLINICAL TRIALS, 2009, 6 (02) : 119 - 125
  • [5] Stopping at nothing? Some dilemmas of data monitoring in clinical trials
    Goodman, Steven N.
    [J]. ANNALS OF INTERNAL MEDICINE, 2007, 146 (12) : 882 - 887
  • [6] Stopping trials for efficacy: an almost unbiased view
    Goodman, Steven N.
    [J]. CLINICAL TRIALS, 2009, 6 (02) : 133 - 135
  • [7] Grant AM, 2005, LANCET, V365, P711
  • [8] Publication bias in clinical trials due to statistical significance or direction of trial results
    Hopewell, Sally
    Loudon, Kirsty
    Clarke, Mike J.
    Oxman, Andrew D.
    Dickersin, Kay
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (01):
  • [9] Stopping or Reporting Early for Positive Results in Randomized Clinical Trials: The National Cancer Institute Cooperative Group Experience From 1990 to 2005
    Korn, Edward L.
    Freidlin, Boris
    Mooney, Margaret
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (10) : 1712 - 1721
  • [10] Montori VM, 2005, JAMA-J AM MED ASSOC, V294, P2203, DOI 10.1001/jama.294.17.2203